Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind double-dummy multicenter study of Kabizi capsules for active ulcerative colitis (Uyghur medicine blue bile type)
CTR20251096Phase 2Active
- Sponsor
- Xinqikang Pharmaceutical
- Start
- Aug 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Kabizi in autoimmune colitis, sponsored by Xinqikang Pharmaceutical. Started Aug 2025; status: active.
02
Drugs
Kabizi
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20251096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251096.